NCT04698018View on ClinicalTrials.gov

A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

April 20, 2021

Primary Completion Date

April 25, 2023

Study Completion Date

April 25, 2023

Conditions
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DRUG

Faster Aspart

Administered s.c. (subcutaneously, under the skin) of the lower abdomen using a pen-injector.

DRUG

Novo Rapid

Administered s.c. (subcutaneously, under the skin) of the lower abdomen using a pen-injector.

Trial Locations (3)

41460

Profil Institut für Stoffwechselforschung GmbH, Neuss

Postal Code: NA

Phase 1 Clinical Trial Centre, Shatin, New Territories, Hong Kong

Unknown

Phase 1 Clinical Trial Centre, Shatin, New Territories

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY